HK1137028A1 - Phosphadiazine hcv polymerase inhibitors iv - Google Patents
Phosphadiazine hcv polymerase inhibitors ivInfo
- Publication number
- HK1137028A1 HK1137028A1 HK10104852.7A HK10104852A HK1137028A1 HK 1137028 A1 HK1137028 A1 HK 1137028A1 HK 10104852 A HK10104852 A HK 10104852A HK 1137028 A1 HK1137028 A1 HK 1137028A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- phosphadiazine
- hcv polymerase
- polymerase inhibitors
- iva
- formulas
- Prior art date
Links
- 229940124683 HCV polymerase inhibitor Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 229940123066 Polymerase inhibitor Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65848—Cyclic amide derivatives of acids of phosphorus, in which two nitrogen atoms belong to the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96723707P | 2007-08-31 | 2007-08-31 | |
PCT/US2008/010225 WO2009032180A1 (en) | 2007-08-31 | 2008-08-28 | Phosphadiazine hcv polymerase inhibitors iv |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1137028A1 true HK1137028A1 (en) | 2010-07-16 |
Family
ID=39874081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10104852.7A HK1137028A1 (en) | 2007-08-31 | 2010-05-18 | Phosphadiazine hcv polymerase inhibitors iv |
Country Status (17)
Country | Link |
---|---|
US (4) | US20090060866A1 (pt) |
EP (1) | EP2183260B1 (pt) |
JP (1) | JP5514108B2 (pt) |
KR (1) | KR20100072002A (pt) |
CN (1) | CN101842378A (pt) |
AT (1) | ATE511514T1 (pt) |
AU (1) | AU2008296997B2 (pt) |
BR (1) | BRPI0815920A2 (pt) |
CA (1) | CA2697546A1 (pt) |
ES (1) | ES2367550T3 (pt) |
HK (1) | HK1137028A1 (pt) |
MX (1) | MX2010002296A (pt) |
NZ (1) | NZ583545A (pt) |
RU (1) | RU2483073C2 (pt) |
TW (1) | TW200927143A (pt) |
UA (1) | UA95715C2 (pt) |
WO (4) | WO2009032179A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2389934A1 (en) * | 2010-05-25 | 2011-11-30 | Sanovel Ilac Sanayi ve Ticaret A.S. | Controlled-Release Tablet Formulations of Pregabalin |
US20120252721A1 (en) | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
WO2015042375A1 (en) | 2013-09-20 | 2015-03-26 | Idenix Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
WO2015134560A1 (en) | 2014-03-05 | 2015-09-11 | Idenix Pharmaceuticals, Inc. | Solid forms of a flaviviridae virus inhibitor compound and salts thereof |
KR20220025914A (ko) | 2015-03-06 | 2022-03-03 | 아테아 파마슈티컬즈, 인크. | HCV 치료를 위한 β-D-2'-데옥시-2'-α-플루오로-2'-β-C-치환된-2-변형된-N6-치환된 퓨린 뉴클레오티드 |
US10766917B2 (en) | 2015-05-27 | 2020-09-08 | Idenix Pharmaceuticals Llc | Nucleotides for the treatment of cancer |
WO2017197055A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Heterocyclic degronimers for target protein degradation |
EP3455218A4 (en) | 2016-05-10 | 2019-12-18 | C4 Therapeutics, Inc. | C3 CARBON-BASED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION |
CN109562113A (zh) | 2016-05-10 | 2019-04-02 | C4医药公司 | 用于靶蛋白降解的螺环降解决定子体 |
WO2018013937A1 (en) | 2016-07-14 | 2018-01-18 | Atea Pharmaceuticals, Inc. | Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection |
CN116036114A (zh) | 2016-09-07 | 2023-05-02 | 阿堤亚制药公司 | 用于rna病毒治疗的2’-取代的-n6-取代的嘌呤核苷酸 |
KR102592899B1 (ko) | 2017-02-01 | 2023-10-24 | 아테아 파마슈티컬즈, 인크. | C형 간염 바이러스를 치료하기 위한 뉴클레오티드 헤미-술페이트 염 |
CN112351799A (zh) | 2018-04-10 | 2021-02-09 | 阿堤亚制药公司 | 具有硬化的hcv感染患者的治疗 |
CN111233925B (zh) * | 2018-11-28 | 2021-03-26 | 上海日馨生物科技有限公司 | 硫胺类化合物、制备方法及其药物组合物 |
US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
CN113698315A (zh) * | 2021-09-03 | 2021-11-26 | 内蒙古蓝科生物科技有限公司 | 一种2-三氟甲基苯甲酰胺的合成方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU495317A1 (ru) * | 1973-11-14 | 1975-12-15 | Киевский научно-исследовательский институт фармакологии и токсикологии | Способ получени этилениминопроизводных 1,2,6-фосфадиазинов |
EP1634886A3 (en) | 1999-03-05 | 2006-03-29 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing prodrug |
EP1724276A1 (en) * | 1999-03-05 | 2006-11-22 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing prodrugs |
WO2000063195A1 (en) * | 1999-04-19 | 2000-10-26 | G.D. Searle & Co. | Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors |
AU2003248566A1 (en) * | 2002-05-24 | 2003-12-12 | Smithkline Beecham Corporation | Novel anti-infectives |
EP1786807B1 (en) * | 2004-08-23 | 2009-07-29 | F.Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
CN101384587B (zh) * | 2006-02-17 | 2011-03-30 | 弗·哈夫曼-拉罗切有限公司 | 抗病毒的杂环化合物 |
-
2008
- 2008-08-27 US US12/198,898 patent/US20090060866A1/en not_active Abandoned
- 2008-08-27 US US12/198,901 patent/US20090060867A1/en not_active Abandoned
- 2008-08-27 US US12/198,900 patent/US20090060872A1/en not_active Abandoned
- 2008-08-27 US US12/198,895 patent/US7932240B2/en active Active
- 2008-08-28 WO PCT/US2008/010224 patent/WO2009032179A1/en active Application Filing
- 2008-08-28 UA UAA201003681A patent/UA95715C2/ru unknown
- 2008-08-28 CA CA2697546A patent/CA2697546A1/en not_active Abandoned
- 2008-08-28 WO PCT/US2008/010220 patent/WO2009032177A1/en active Application Filing
- 2008-08-28 BR BRPI0815920-3A2A patent/BRPI0815920A2/pt not_active IP Right Cessation
- 2008-08-28 AT AT08829413T patent/ATE511514T1/de not_active IP Right Cessation
- 2008-08-28 ES ES08829413T patent/ES2367550T3/es active Active
- 2008-08-28 WO PCT/US2008/010219 patent/WO2009032176A1/en active Application Filing
- 2008-08-28 KR KR1020107006918A patent/KR20100072002A/ko not_active Application Discontinuation
- 2008-08-28 JP JP2010522959A patent/JP5514108B2/ja not_active Expired - Fee Related
- 2008-08-28 CN CN200880114339A patent/CN101842378A/zh active Pending
- 2008-08-28 WO PCT/US2008/010225 patent/WO2009032180A1/en active Application Filing
- 2008-08-28 MX MX2010002296A patent/MX2010002296A/es active IP Right Grant
- 2008-08-28 RU RU2010112408/04A patent/RU2483073C2/ru not_active IP Right Cessation
- 2008-08-28 EP EP08829413A patent/EP2183260B1/en active Active
- 2008-08-28 NZ NZ583545A patent/NZ583545A/en not_active IP Right Cessation
- 2008-08-28 AU AU2008296997A patent/AU2008296997B2/en not_active Ceased
- 2008-08-29 TW TW097133383A patent/TW200927143A/zh unknown
-
2010
- 2010-05-18 HK HK10104852.7A patent/HK1137028A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20090081158A1 (en) | 2009-03-26 |
JP5514108B2 (ja) | 2014-06-04 |
UA95715C2 (ru) | 2011-08-25 |
AU2008296997B2 (en) | 2013-08-29 |
CA2697546A1 (en) | 2009-03-12 |
ATE511514T1 (de) | 2011-06-15 |
JP2010537986A (ja) | 2010-12-09 |
MX2010002296A (es) | 2010-04-01 |
BRPI0815920A2 (pt) | 2015-02-18 |
CN101842378A (zh) | 2010-09-22 |
ES2367550T3 (es) | 2011-11-04 |
TW200927143A (en) | 2009-07-01 |
US20090060872A1 (en) | 2009-03-05 |
RU2010112408A (ru) | 2011-10-10 |
US20090060867A1 (en) | 2009-03-05 |
WO2009032179A1 (en) | 2009-03-12 |
US7932240B2 (en) | 2011-04-26 |
WO2009032176A1 (en) | 2009-03-12 |
WO2009032177A1 (en) | 2009-03-12 |
RU2483073C2 (ru) | 2013-05-27 |
EP2183260B1 (en) | 2011-06-01 |
EP2183260A1 (en) | 2010-05-12 |
AU2008296997A1 (en) | 2009-03-12 |
KR20100072002A (ko) | 2010-06-29 |
WO2009032180A1 (en) | 2009-03-12 |
US20090060866A1 (en) | 2009-03-05 |
NZ583545A (en) | 2011-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1137028A1 (en) | Phosphadiazine hcv polymerase inhibitors iv | |
MX2010008523A (es) | Inhibidores macrociclicos de serina proteasa. | |
GEP20125511B (en) | Mapk/erk kinase inhibitors | |
MX2009006535A (es) | Derivados de indol-4-il-pirimidinil-2-il-amina y su uso como inhibidores de cinasa dependiente de ciclina. | |
PH12014500053A1 (en) | Proteasome inhibitors | |
MX2009008617A (es) | Uso de antagonistas de interleucina-23 para el tratamiento de infeccion. | |
MY148534A (en) | Inhibitors of human immunodeficiency virus replication | |
CL2008001633A1 (es) | Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer. | |
NZ585226A (en) | Inhibitors of human immunodeficiency virus replication | |
NO20082120L (no) | Behandling og forebyggelse av mikroangiopati | |
MY159958A (en) | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors | |
GEP20146060B (en) | Pyridyl inhibitors of hedgehog signalling | |
UA99284C2 (ru) | ИНГИБИТОРЫ р70 S6-КИНАЗЫ | |
MX2009004707A (es) | Piridina carboxamides como inhibidores 11-beta-hsd1. | |
MX2012003644A (es) | Compuestos de 2-piridona empleados como inhibidores de la elastasa neutrofila. | |
CL2008003511A1 (es) | Compuestos derivados nucleotidicos, inhibidores de polimerasa ns5b del virus de la hepatitis c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. | |
WO2011113060A3 (en) | Antiviral compounds and methods of use thereof | |
CL2008001740A1 (es) | Compuestos derivados de piperidinas sustituidas, inhibidores de la dna-girasa y/o topoisomerasa iv; procedimeinto para su preparacion; composiicon farmaceutica que comprende estos compustos y su uso en el tratamiento de una infeccion bacteriana. | |
WO2011150190A3 (en) | Hcv inhibitor compounds and methods of use thereof | |
WO2010101967A3 (en) | Phosphothiophene and phosphothiazole hcv polymerase inhibitors | |
ATE531721T1 (de) | Cyanoaminochinolone als gsk-3-inhibitoren | |
WO2012061248A3 (en) | Novel specific hcv ns3 protease inhibitors | |
CL2008002082A1 (es) | Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades. | |
CL2007001542A1 (es) | Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas. | |
PH12015500185A1 (en) | Azaheterocycles as bir2 and/or bir3 inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170828 |